Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 707-713

  Purkerson, Sherry L ^a   Potter, Lincoln T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CLOZAPINE; GALLAMINE; HEXAHYDRODIFENIDOL; HIMBACINE; HYOSCYAMINE; METHOCTRAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; PIRENZEPINE; SILAHEXOCYCLIUM; TRIHEXYPHENIDYL; TRIPITRAMINE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAT; CORPUS STRIATUM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0031886149     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ariano MA, Larson ER and Noblett KL (1995) Cellular dopamine receptor subtype localization, in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano M and Surmeier J eds), pp 59-70, R. G. Landes Co, New York, NY.
2. Bernard V, Normand E and Bloch B (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 12:3591-3600.
3. Bolam JP and Bennett BD (1995) Microcircuitry of the neostriatum, in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano M and Surmeier J eds), pp 1-19, R. G. Landes Co, New York, NY.
4. Bolden C, Cusack B and Richelson E (1991) Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. Eur J Phamacol 192:205-206.
5. Bolden C, Cusack B and Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260:576-580.
6. Buckley NJ, Bonner TI, Buckley CM and Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469-476.
7. Carsi-Gabrenas J (1997) New toxins from the venom of Dendraspis angusticeps. PhD Dissertation. University of Miami, Coral Gables, FL.
8. Cuevas J, Harper AA, Trequattrini C and Adams DJ (1997) Passive and active membrane properties of isolated rat intracardiac neurons: regulation by H-and M-currents. J. Neurophysiol. 78:1890-1902.
9. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
10. Dong GZ, Kameyama K, Rinken A and Haga T (1995) Ligand binding properties of muscarinic acetylcholine subtypes (m1-m5) expressed in baculovirus-infected insect cells. J Phamacol Exp Ther 274:378-384.
11. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E and Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
12. Ferrari-DiLeo G, Waelbroeck M, Mash DC and Flynn DD (1994) Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol Pharmacol 46:1028-1035.
13. 3H-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Synapse 14:283-296.
14. Geneser-Jensen FA and Blackstad TW (1971) Distribution of acetylcholinesterase in the hippocampal region of the guinea pig. Z Zellforsch Mikrosk Anat 114:460-481.
15. Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal gangli. Trends Neurol Sci 13:244-253.
16. Graybiel AM and Ragsdale CW (1983) Biochemical anatomy of the striatum, in Chemical Neuroanatomy (Emson PC ed), pp 427-504, Raven Press, New York.
17. Hersch SM, Gutekunst C-A, Rees HD and Levey AI (1994) Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: Light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14:3351-3363.
18. Jerusalinsky D and Harvey AL (1995) Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 15:424-430.
19. Jolkkonen M (1996) Muscarinic toxins from Dendroaspis (mamba) venom. Acta Univ. Uppsala, Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 183, Uppsala, Sweden.
20. Le Moine C and Bloch B (1995) Anatomical and cellular analysis of dopamine receptor gene expression in striatal neurons, in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano M and Surmeier J eds), pp 45-57, R. G. Landes Co, New York, NY.
21. Lazareno S, Farries T and Birdsall NJM (1993) Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1-M4. Life Sci 52:449-456.
22. Levey AI (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448.
23. Levey AI, Kitt CA, Simonds WF, Price DL and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3218-3226.
24. Li M, Yasuda RP, Wall SJ, Wellstein A and Wolfe BB (1991) Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Mol Pharmacol 40:28-35.
25. Liang JS, Carsi-Gabrenas JM, Krajewski JL, McCafferty JM, Purkerson SL, Santiago MP, Strauss WL, Valentine HH and Potter LT (1996) Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon 34:1257-1267.
26. Maggio R, Barbier P, Bolognesi ML, Minarini A, Tedeschi D and Melchiorre C (1994) Binding profile of the selective muscarinic receptor antagonist, tripitramine. Eur J Pharmacol 268:459-462.
27. Marino MJ, Potter LT and Conn PJ (1997) The muscarinic receptor subtype mediating NMDA receptor current potentiation. Neurosci Abstr 23:2020.
28. Mash DC and Potter LT (1986) Autoradiographic localization of M1 and M2 muscarine recepstors in the rat brain. Neuroscience 19:551-564.
29. Max SI, Liang J-S and Potter LT (1993a) Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci 13:4293-4300.
30. Max SI, Liang J-S, Valentine HH and Potter LT (1993b) Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J Pharmacol Exp Ther 267:480-485.
31. Max SI, Liang J-S and Potter LT (1993c) Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol 44:1171-1175.
32. Max SI, Liang J-S, Purkerson SL and Potter LT (1993d) m4-Toxin, a selective, reversible, allosteric antagonist of m4 muscarinic receptors. Neurosci Abstr 19:462.
33. McKinney M, Miller JH, Gibson VA, Nickelson L and Aksoy S (1991) Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition. Mol Pharmacol 40:1014-1022.
34. Morelli M, Cozzolino A, Pinna A, Carta A and DiChiara G (1993) Blockade of muscarinic receptor potentiates D1 dependent turning behavior in 6-hydroxydopamine-lesioned rats. Neuroscience 53:673-678.
35. Potter LT and Ferrendelli CA (1989) Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors. J Pharmacol Exp Ther 248:974-978.
36. Potter LT, Ferrendelli CA and Hanchett HE (1988) Two affinity states of M1 muscarine receptors. Cell Mol Neurobiol 8:181-191.
37. Potter LT, Flynn DD, Hanchett HE, Kalinoski DL, Luber-Narod J and Mash DC (1984) Independent M1 and M2 receptors: Ligands, autoradiography and functions. Trends Pharmacol Sci Suppl:22-31.
38. 2 receptors. Mol Pharmacol 39:211-221.
39. Potter LT and Purkerson SL (1995) Pharmacology of striatal muscarinic receptors, in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano M and Surmeier J eds), pp 241-254, R. G. Landes Co, New York, NY.
40. Surmeier DJ, Cantrell AR and Carter-Russell H (1995) Dopaminergic and cholinergic modulation of calcium conductances in neostriatal neurons,in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano M and Surmeier J), pp 193-215, R. G. Landes Co, New York, NY.
41. 4) in rat brain. Mol Pharmacol 38:267-273.
42. Wei J, Walton EA, Milici A and Buccafusco, J. J (1994) m1-m5 Muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J Neurochem 63:815-821.
43. Weiner DM, Levey AI and Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptors mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054.
44. Wang JQ, Jolkkonen M and McGinty JF (1997) Muscarinic toxin 3 (MT3), a muscarinic M4 receptor-selective antagonist, increases neuropeptide mRNAs in rat striatum. Neurosci Abstr 23:2020, 1997.